Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1999 May;89(5):662–665. doi: 10.2105/ajph.89.5.662

Methadone dosing, heroin affordability, and the severity of addiction.

P B Bach 1, J Lantos 1
PMCID: PMC1508716  PMID: 10224975

Abstract

OBJECTIVES: This study sought to track changes in US heroin prices from 1988 to 1995 and to determine whether changes in the affordability of heroin were associated with changes in the use of heroin by users seeking methadone treatment, as indexed by methadone dose levels. METHODS: Data on the price of heroin were from the Drug Enforcement Administration; data on methadone doses were from surveys conducted in 1988, 1990, and 1995 of 100 methadone maintenance centers. Multivariable models that controlled for time and city effects were used to ascertain whether clinics in cities where heroin was less expensive had patients receiving higher doses of methadone, which would suggest that these patients had relatively higher physiological levels of opiate addiction owing to increased heroin use. RESULTS: The amount of pure heroin contained in a $100 (US) purchase has increased on average 3-fold between 1988 and 1995. The average dose of methadone in clinics was positively associated with the affordability of local heroin (P < .01). CONCLUSIONS: When heroin prices fall, heroin addicts require more methadone (a heroin substitute) to stabilize their addiction--evidence that they are consuming more heroin.

Full text

PDF
663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cherubin C. E., Sapira J. D. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993 Nov 15;119(10):1017–1028. doi: 10.7326/0003-4819-119-10-199311150-00009. [DOI] [PubMed] [Google Scholar]
  2. D'Aunno T., Vaughn T. E. Variations in methadone treatment practices. Results from a national study. JAMA. 1992 Jan 8;267(2):253–258. [PubMed] [Google Scholar]
  3. Dole V. P., Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978;311:181–189. doi: 10.1111/j.1749-6632.1978.tb16775.x. [DOI] [PubMed] [Google Scholar]
  4. French M. T., Mauskopf J. A., Teague J. L., Roland E. J. Estimating the dollar value of health outcomes from drug-abuse interventions. Med Care. 1996 Sep;34(9):890–910. doi: 10.1097/00005650-199609000-00003. [DOI] [PubMed] [Google Scholar]
  5. Haverkos H. W., Lange W. R. From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis. 1990 May;161(5):894–902. doi: 10.1093/infdis/161.5.894. [DOI] [PubMed] [Google Scholar]
  6. Hyatt R. R., Jr, Rhodes W. The price and purity of cocaine: the relationship to emergency room visits and death, and to drug use among arrestees. 1995 Mar 15-Apr 15Stat Med. 14(5-7):655–668. doi: 10.1002/sim.4780140522. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES